Top 5 Pharma R&D Spenders in Europe
The Top Five countries in Europe ranked by amount spent on pharma R&D. While some of the continent’s largest and most developed nations are…
Tagged with Research
IRBM CSO Carlo Toniatti on the Evolving CRO Role in Drug…
Carlo Toniatti, chief scientific officer of IRBM, gives his insights into how the increased participation of early-stage ventures in the drug R&D…
Nicolas Dumoulin – General Manager & Head of Human…
Boehringer Ingelheim’s Nicolas Dumoulin outlines Denmark’s relevance to the German family-owned company, including the strong uptake of its…
Jakob Skaarup Nielsen – CEO, Healthcare DENMARK
Healthcare DENMARK is a non-profit organization and public-private partnership representing Danish healthcare stakeholders internationally. Jakob…
New EFPIA President Hubertus von Baumbach on Building Back Better…
Boehringer Ingelheim’s Hubertus von Baumbach, the newly appointed president of the European Federation of Pharmaceutical Industries and Associations…
Hamdi Akan – Head of the Executive Board, Clinical Research…
Dr Hamdi Akan, head of Turkey’s Clinical Research Association, dives into the country’s opportunities and barriers to become a clinical trials…
Senthil Sockalingam – Head of IQVIA Biotech, JAPAC &…
IQVIA Biotech JAPAC’s Dr Senthil Sockalingam outlines the evolving needs of the flood of early-stage drug discovery ventures in Asia, how biotechs…
Ashok Venkitaraman – Director, Cancer Science Institute of…
Professor Ashok Venkitaraman introduces his work in Singapore, coordinating and catalysing research on the causes of cancer in Asia, and translating…
Beh Kian Teik – Deputy CEO, National Research Foundation…
Beh Kian Teik of Singapore’s National Research Foundation (NRF) outlines the importance of the life sciences within the country’s innovation…
Christiane von der Eltz – Country Speaker, Merck…
Merck Switzerland’s Christiane von der Eltz highlights the German firm’s recent big investments in Switzerland and how it forms a key part of…
René P Buholzer – CEO, Interpharma, Switzerland
Interpharma’s Dr René P. Buholzer highlights the key lessons that Switzerland’s innovative pharmaceutical industry has taken from the COVID-19…
Opportunities for the Life Science Industry in Australia…
Regular PharmaBoardroom contributor Brendan Shaw outlines how his home country of Australia has so far successfully managed to avoid the worst of the…
